25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density

J Pediatr. 1991 Oct;119(4):657-60. doi: 10.1016/s0022-3476(05)82424-2.

Authors

A Reed¹, M Haugen, L M Pachman, C B Langman

Affiliation

¹ Division of Rheumatology/Immunology, Northwestern University, Chicago, Ill.

PMID: 1919903
DOI: 10.1016/s0022-3476(05)82424-2

No abstract available

MeSH terms

25-Hydroxyvitamin D 2 / therapeutic use*
Adolescent
Arthritis, Juvenile / drug therapy*
Bone Density / drug effects*
Child
Child, Preschool
Female
Humans
Male
Osteocalcin / blood*
Parathyroid Hormone / blood

Substances

Parathyroid Hormone
Osteocalcin
25-Hydroxyvitamin D 2